-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Maintains Outperform on Imax, Raises Price Target to $42

Benzinga·12/08/2025 12:57:17
Listen to the news
Barrington Research analyst Patrick Sholl maintains Imax (NYSE:IMAX) with a Outperform and raises the price target from $37 to $42.